• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

71 Percent of Mpox Cases Occurred in Large Central Urban Areas

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 25, 2023 -- About 71 percent of cases of mpox occurred among persons residing in large central urban areas, and 95.7 percent of these cases occurred in cisgender men, according to research published in the May 26 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Carla E. Zelaya, Ph.D., from the CDC Mpox Emergency Response Team, and colleagues describe urban-rural differences in mpox incidence (cases per 100,000 population) among persons aged 15 to 64 years by gender and race and ethnicity.

The researchers identified substantial differences in incidence by urbanicity, gender, and race and ethnicity. Seventy-one percent of cases occurred among persons residing in large central urban areas; of these, 95.7 percent were in cisgender men. In the United States, the overall incidence of mpox was 13.5; in both urban and rural areas, incidence peaked in August. Incidence in rural areas was about 4 and 11 percent of that in large central urban areas among cisgender men and women, respectively (risk ratios, 0.04 and 0.11, respectively). Incidence was consistently higher among non-Hispanic Black or African American and Hispanic or Latino persons than among non-Hispanic Whites in both urban and rural areas; the risk ratios between Black and White persons were highest in rural areas.

"The estimated higher incidence in urban areas underscores the need for services, especially in large central urban areas; however, mpox prevention, recognition, diagnosis, and treatment services are still needed in less urban and rural areas," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.